MER Primary Care Conferences Internal Medicine for Primary Care Geri Neuro Rheum Sep 25-27, 2026

Neurologic symptoms, joint disorders and cardiovascular care in older adults are the focus of this MER review. The September 25–27, 2026 program at Wynn Las Vegas begins with weakness, dementia and headaches, then examines joint pain, arthritis medicines, gout and fibromyalgia. Later sessions address cerebrovascular disorders, heart failure and hypertension in older adults, with discussion periods devoted to the two cardiovascular topics. The material is relevant to primary care clinicians who need to distinguish overlapping symptoms and review treatment choices across specialties. The original three-day agenda is reproduced below, including its session descriptions and discussion topics.

Package scope: The agenda describes the original conference, not a verified inventory of supplied files. Recording coverage, formats and completeness remain unconfirmed. MER registration, publisher accounts and live participation are not included.

Topics

• Friday, September 25, 2026

  • Neurology: Evaluating Weakness (Using history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system)

  • Neurology: Alzheimer’s & Other Dementias (Definition; statistics; neurological changes of normal aging; pathology; etiological theories; vascular dementias; investigations; social issues; symptomatic treatment; research therapies)

  • Neurology: Headaches & Migraines (Basic headache mechanisms; headache history: characteristics, precipitating factors, medical conditions; migraine: common tension, classic, treatment, complicated, cluster, sinus; trigeminal neuralgia; Giant Cell Arteritis; brain tumor; subarachnoid hemorrhage; emergency room treatment)

  • Rheumatology: Evaluating the Patient with Joint Pain (Differentiating between inflammatory and non-inflammatory joint pain; the utility of joint aspiration and lab work-up with interpretation of synovial fluid analysis; differential diagnosis of joint pain and inflammatory arthritis)

  • Rheumatology: Update in Pharmacology for Arthritis (Review risks and benefits of traditional NSAIDs and COX-2 inhibitors; analgesics [narcotics and tramadol], acetaminophen, conventional-synthetic DMARDs, and bDMARDs)

• Saturday, September 26, 2026

  • Rheumatology: Crystal Disease: Gout & Pseudogout (Properly diagnosing and treating crystal diseases such as gout and pseudogout)

  • Rheumatology: Fibromyalgia (Differential diagnosis and treatment of this difficult-to-manage pain syndrome; treatment options of anti-epileptics and SNRIs)

  • Neurology: Cerebrovascular Disorders (Epidemiology; identifying the high-risk patient; treatment effects; transient neurological deficit: carotid, vertebrobasilar; non-specific cerebral symptoms; migraines vs. TIA; treatment options)

  • Geriatrics: Heart Failure in Older Adults (Recognition of the high mortality associated with heart failure; understanding how to diagnose heart failure and the difference between reduced ejection fraction and preserved ejection fraction heart failure; evidence-based treatments available for heart failure)

  • Geriatrics: Heart Failure Discussion and Q&A (Interactive review of the principles of heart failure diagnosis and treatment in older adults, and audience questions further clarifying the topic)

• Sunday, September 27, 2026

  • Geriatrics: Controversies in the Management of Hypertension in Older Adults (Best evidence for treatment goals for hypertension in diabetics and those with previous stroke; controversial evidence for the various guidelines for diagnosing and treating hypertension in older adults; best evidence-based medications for hypertension)

  • Geriatrics: Hypertension Discussion and Q&A (Interactive review of the principles of hypertension diagnosis and treatment in older adults, and audience questions further clarifying the topic)